当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析

国际医学

(000516)

  

流通市值:113.77亿  总市值:115.53亿
流通股本:22.05亿   总股本:22.39亿

国际医学(000516)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-2.18亿元,每股收益-0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益320997.60万元,未分配利润-14499.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1000551.17万元,负债679553.57万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,034,307,690.46997,091,245.374,815,466,752.343,606,256,924.42
营业总成本2,279,057,237.691,144,868,275.735,180,946,550.963,892,721,588.98
其他经营收益
营业利润-211,663,325.64-128,892,235.38-342,182,324-283,406,415.63
利润总额-213,131,740.97-130,667,276.25-344,644,061.86-283,483,908.67
净利润-218,312,970.23-132,959,986.79-365,139,719.05-294,272,771.9
每股收益
其他综合收益----
综合收益总额-218,312,970.23-132,959,986.79-365,139,719.05-294,272,771.9
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,185,953,128.621,357,462,403.541,615,075,051.841,461,576,314.49
非流动资产:
非流动资产合计8,819,558,543.58,961,380,479.319,021,246,941.059,092,490,561.88
资产总计10,005,511,672.1210,318,842,882.8510,636,321,992.8910,554,066,876.37
流动负债:
流动负债合计4,210,763,756.214,075,263,256.044,151,485,482.843,931,333,257.16
非流动负债:
非流动负债合计2,584,771,936.462,904,549,572.583,012,846,469.033,144,207,591.43
负债合计6,795,535,692.676,979,812,828.627,164,331,951.877,075,540,848.59
所有者权益(或股东权益):
归属于母公司股东权益合计3,466,264,833.363,568,573,896.313,674,927,755.193,652,616,319.1
股东权益合计3,209,975,979.453,339,030,054.233,471,990,041.023,478,526,027.78
负债和股东权益合计10,005,511,672.1210,318,842,882.8510,636,321,992.8910,554,066,876.37
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,235,548,073.731,076,605,731.634,839,806,934.783,544,589,105.11
经营活动现金流出小计1,643,006,109.68832,801,572.273,830,687,121.572,920,901,989.24
经营活动产生的现金流量净额592,541,964.05243,804,159.361,009,119,813.21623,687,115.87
投资活动产生的现金流量:
投资活动现金流入小计88,210,678.8978,194,869.3952,552,409.0352,055,463.63
投资活动现金流出小计207,482,673.01149,882,648.02558,740,389.83458,211,576.8
投资活动产生的现金流量净额-119,271,994.12-71,687,778.63-506,187,980.8-406,156,113.17
筹资活动产生的现金流量:
筹资活动现金流入小计203,010,00099,980,000717,480,000557,630,000
筹资活动现金流出小计959,029,573.49451,055,002.21,615,812,467.851,291,640,695.1
筹资活动产生的现金流量净额-756,019,573.49-351,075,002.2-898,332,467.85-734,010,695.1
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-282,749,603.56-178,958,621.47-395,400,635.44-516,479,692.4
期末现金及现金等价物余额265,812,399.82369,603,381.91548,562,003.38427,482,946.42
补充资料:
现金及现金等价物的净增加额-282,749,603.56--395,400,635.44-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东海证券杜永宏-0.06-0.040.012025-08-26
TOP↑